Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S.I. Lopes
Pin64 - Dolutegravir Plus Lamivudine for the Treatment of Naïve Adults Living With Hiv-1: A Uk Cost-Minimization Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naive Adults With Hiv-1 Infection in the United Kingdom
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost Calculation for a Flash Glucose Monitoring System for UK Adults With Type 1 Diabetes Mellitus Receiving Intensive Insulin Treatment
Diabetes Research and Clinical Practice
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
96-Week Results of Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Plus Efavirenz, in Antiretroviral-Naive, HIV-1-infected Adults: ASSERT Study
Antiviral Therapy
Infectious Diseases
Pharmacology
Prevalence of HIV-1 Integrase Mutations Related to Resistance to Dolutegravir in Raltegravir Naïve and Pretreated Patients
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Lipid Profile Improvement in Virologically Suppressed HIV-1-infected Patients Switched to Dolutegravir/Abacavir/Lamivudine: Data From the SCOLTA Project
Infection and Drug Resistance
Infectious Diseases
Pharmacology
Clinical Effectiveness of Dolutegravir in the Treatment of HIV/AIDS
Infection and Drug Resistance
Infectious Diseases
Pharmacology
The Prevalence of HIV-1 Drug Resistance Among Antiretroviral Treatment Naïve Individuals in Mainland China: A Meta-Analysis
PLoS ONE
Multidisciplinary
The Cost-Effectiveness of Hepatitis C Treatments in Treatment Naïve Genotype 1 Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Two’s a Company, Three’s a Crowd: A Review of Initiating or Switching to a Two-Drug Antiretroviral Regimen in Treatment-Naïve and Treatment-Experienced Patients Living With HIV-1
Infectious Diseases and Therapy
Infectious Diseases
Microbiology
